Anti-Interferon Beta

Polyclonal Antibody
Cat. # 06-1095 pack size: 200 µL
Lot # 2712480 120,000 Units Certificate of Analysis
page 1 of 2
FOR RESEARCH USE ONLY Store at -20°C

Species Antibody Epitope/ Host Molecular

Applications Accession #
Cross-Reactivity Isotype Region Species Weight
NEUT, WB, IH(P) H, B N/A Internal Rb 18 kDa NP_002167

Background Storage and Handling

Interferon beta is a type I IFN regulatory
cytokine belonging to a conserved family of
secreted proteins that have demonstrated
growth-inhibitory, immunomodulatory and
antiviral properties. Due to these properties,
the type I IFNs have been of considerable
interest and use in various clinical functions.
Studies have shown Interferon beta to be a
potent immunomodulator and tumor growth
suppressor through the down-regulation of
MGMT. Also, there has been great interest in
this cytokine as a possible approach to gene
therapy for patients infected with AIDS.
Presentation
Rabbit polyclonal containing serum with 0.05%
sodium azide.
Specificity
This antibody recognizes Interferon beta.
Bioactivity
1.2 x 10^5 Units @ 6.0 x 10^5 Neutralization
Units/mL
Species Cross-reactivity
Demonstrated to react with human and bovine
Rhesus monkey and chimpanzee (91%
sequence homology)
Immunogen
KLH-conjugated linear peptide corresponding
to the internal domain of human Interferon
Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and
prior to removing the cap, centrifuge the vial
and gently mix the solution. Aliquot into
microcentrifuge tubes and store at -20°C.
Avoid repeated freeze/thaw cycles, which may
damage IgG and affect product performance.
Control
Recombinant human Interferon Beta
Quality Control Testing
Evaluated by Western Blotting in recombinant References
human Interferon beta. 1. Rosati, S., et al. (2008). Molecular Cancer
Ther. 7:3852-3858.
2. Davidoff, A., et al. (2007). Mol. Cancer Res.
5:531-542.
Western Blotting Analysis: A 1:500 dilution of
3. Vitale, G., et al. (2006). Cancer Research. 66:
this antibody detected 10 µg of recombinant 554-562.
human Interferon Beta. 4. Deonarain, R., et al. (2003). PNAS. 100(23):
13453-13458.
5. Vieillard, V., et al. (1997). PNAS. 94(21):
11595-11600.
6. Rubinstein S. F., et al. (1981). Journal of
Western Blotting Analysis: Virology. 37:755-758.
Representative lot data.
Recombinant human Interferon
beta was resolved by
electrophoresis, transferred to
PVDF membranes and probed with
Anti-Interferon beta (1:500 dilution).
Proteins were visualized using a
Donkey Anti-Rabbit IgG conjugated
to HRP and chemiluminescence
detection system.
Arrow indicates Interferon beta
(~18 kDa).

beta
Molecular Weight Neutralizing Activity Assay Analysis:
Representative lot data.
~ 18 kDa Neutralization activity is measured by the
inhibition of VSV infection of MDBK cells in the
presence of the neutralizing antibody (ability of
the antibody to block interferon's protection of
MDBK from VSV infection). This antibody has a
Rev.B/2014-06-26/06-1095CA/RB

neutralization activity of 6.0 x 10^5 units/mL, as

compared to Catalog # AB1431. (Note:
Interferon Beta response is species specific)

APPLICATION LEGEND: WB Western Blotting IP Immunoprecipitation IC Immunocytochemistry IF Immunofluorescence

IH Immunohistochemistry (Tissue) IH(P) Immunohistochemistry (Paraffin) FC Flow Cytometry NEUT Neutralizing
SPECIES LEGEND: H Human M Mouse R Rat Rb Rabbit WR Most Common Vertebrates
Please visit www.millipore.com for additional product information, test data and references.
Submit your published journal article, and earn credit toward future Millipore purchases. Visit www.millipore.com/publicationrewards to learn more!
Anti-Interferon Beta
Cat # 06-1095
Lot # 2712480 page 2 of 2

Additional Research Applications

Neutralizing Activity Assay Analysis: One unit of neutralization activity is defined as the amount of antibody serum required to inactivate one unit
of Interferon Beta activity in a viral resistant assay, i.e., VSV virus and MDBK cell line (Rubinstein S. Familletti, P.C. and Pestka S. Journal of
Virology, 1981, 37:755-758). Neutralization activity is measured by the inhibition of VSV infection of MDBK cells in the presence and absence of
the neutralization antibody (ability of the antibody to block interferon's protection of MDBK from VSV infection). This antibody has a neutralization
activity of 6.0 x 10^5 units/mL. (Note: Interferon Beta response is species specific)

Immunohistochemistry (Paraffin) Analysis: A 1:500 dilution from a previous lot detected Interferon Beta in benign prostate tissue.

Immunohistochemistry (Paraffin) Analysis:

Representative lot data.
Paraffin-embedded benign prostate tissue was prepared using
heat-induced epitope retrieval in citrate buffer, pH 6.0.
Immunostaining was performed using a 1:500 dilution of Anti-
Interferon Beta. Reactivity was detected using the IHC-Select
Detection Kit (Cat. No. DAB050). Staining pattern appears to
be restricted to the plasma membrane of benign prostate
gland cells.

PROTOCOL

Western Blotting
1. Perform SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on cell lysate and transfer the proteins to a PVDF membrane. Wash the
PVDF membrane twice with water.
2. Block the blotted PVDF membrane in freshly prepared 5% BSA or milk with 0.05% Tween®-20 for 1 hour at room temperature with constant
agitation.
3. Incubate the PVDF with the recommended dilution of the primary antibody, diluted in freshly prepared 5% BSA or milk for 1 hour at room
temperature or overnight with agitation at 2-8°C.
4. Wash the PVDF 3 times with TBST.
5. Incubate the PVDF in the secondary reagent of choice in 5% milk for 1 hour with agitation at room temperature.
6. Wash the PVDF 3-5 times with TBST.
7. Use Spray and Glow Catalog # 17-373 to visualize results. Use as directed.

RELATED PRODUCTS (specific) RELATED PRODUCTS (non-specific)

cat # description cat # description
MAB1155 Anti-Interferon-α/β Receptor Chain 2, clone MMHAR-2 WBAVDBASE SNAP i.d. Protein Detection System
MAB416 Anti-Interferon-β, clone A1 WBAVDABTR SNAP i.d. Antibody Collection Tray
AB2215 Anti-Interferon-β WBAVDR0LL SNAP i.d. Blot Roller
AP182P Donkey anti-Rabbit IgG, HRP conjugate WBAVDBH03 SNAP i.d. Triple Well Blot Holder
WBAVDBH01 SNAP i.d. Single Well Blot Holder
WBAVDBH02 SNAP i.d. Double Well Blot Holder
IPVH00010 Immobilon-P 26.5 cm x 3.75 m Roll PVDF 0.45 µm
IPFL00010 Immobilon-FL 26.5 cm x 3.75 m Roll PVDF 0.45 µm
IPVH07850 Immobilon-P 7 x 8.4 cm PVDF 0.45 mm (sheet) 50/pk
ISEQ00010 Immobilon-P SQ 26.5 cm x 3.75 m 1 roll PVDF 0.2 µm
ISEQ07850 Immobilon-P 7 x 8.4 cm PVDF 0.2 mm (sheet) 50/pk
IPFL07810 Immobilon-FL 7 x 8.4 cm PVDF 0.45 mm (sheet) 10/pk
WBKLS0100 Immobilon Western Chemilum HRP Substrate 100 mL
17-373 Spray & Glow™ ECL WB Detection System 1 ea
2060 Re-Blot Western Blot Recycling Kit
2500 Re-Blot Plus Western Blot Recycling Kit
B2080-175GM Blot Quick Blocker Membrane Blocking Agent 175G

antibodies Multiplex products biotools cell culture enzymes kits proteins/peptides siRNA/cDNA products

Please visit www.millipore.com for additional product information, test data and references
EMD Millipore Corporation, 28820 Single Oak Drive, Temecula, CA 92590, USA 1-800-437-7500
Technical Support: T: 1-800-MILLIPORE (1-800-645-5476) • F: 1-800-437-7502
FOR RESEARCH USE ONLY. Not for use in diagnostic procedures. Not for human or animal consumption. Purchase of this Product does not include any right to resell or transfer,
either as a stand-alone product or as a component of another product. Any use of this Product for purposes other than research is strictly prohibited.
Merck Millipore, the M mark, Upstate, Chemicon, Linco and all other trademarks, unless specifically identified above in the text as
belonging to a third party, are owned by Merck KGaA, Darmstadt. Copyright ©2008-2016 Merck KGaA, Darmstadt Germany. All rights reserved.